Growth Metrics

Nektar Therapeutics (NKTR) Amortization - Goodwill (2023)

Nektar Therapeutics has reported Amortization - Goodwill over the past 1 years, most recently at $76.5 million for Q1 2023.

  • Quarterly results put Amortization - Goodwill at $76.5 million for Q1 2023, changed N/A from a year ago — trailing twelve months through Dec 2023 was $76.5 million (changed N/A YoY), and the annual figure for FY2023 was $76.5 million, changed.
  • Amortization - Goodwill for Q1 2023 was $76.5 million at Nektar Therapeutics.
  • Over the last five years, Amortization - Goodwill for NKTR hit a ceiling of $76.5 million in Q1 2023 and a floor of $76.5 million in Q1 2023.